Stocks · Health care · Pharmaceutical Preparations

iBio, Inc.

IBIO Clue Score37
United States Fiscal year ends June CIK 0001420720 Results filed 28 Aug 2026

What the insiders did No buying or selling

By person

7 insiders · 0 transactions
0.0×

Dr. Martin B. Brenner holds only 0.0 times base salary in stock. $53.95K of shares against $580.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Dr. Martin B. Brenner last reported holding, valued at $1.76, the price Common Stock was last bought or sold at on the open market here, on 26 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Antonio Bernardino Guimaraes Parada
Director
—
—
—
183,823
$323.53K
—
Felipe Duran
Chief Financial Officer
—
—
—
35,974
$63.31K
+1,747%
Martin Brenner
See Remarks
—
—
—
30,652
$53.95K
+235.9%
Marc Banjak
Chief Legal Officer
—
—
—
25,000
$44.00K
+1,233%
David Arkowitz
Director
—
—
—
18,382
$32.35K
—
Gary Sender
Director
—
—
—
9,191
$16.18K
—
William D Clark
Director
—
—
—
1,838
$3.23K
—

No percentages here. This company's share count has moved by a factor of 6.5 over the window, from 9,874,676 to 64,307,256 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.